Rotavirus vaccine, live, oral, pentavalent was licensed for use in infants ages 6 to 32 weeks
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
On Feb. 3, 2006, Rotavirus vaccine, live, oral, pentavalent (RotaTeq by Merck) was licensed for use in infants…
On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…